ABSTRACTS
ASTHMA, ALLERGY AND COPD 2006 – from the science to daily practice
GINA and the Patient
Suzanne S. Hurd ................................................................................................................ 6
Global Allergy and Asthma European Network (GA2LEN) and the Patient
P. Van Cauwenberge .......................................................................................................... 7
The patient Perspectives
Svein-Erik Myrseth ............................................................................................................ 8
How do we genuinely enhance doctor-patient partnership?
Martyn R Partridge............................................................................................................ 9
Primary Prevention of Allergy and Asthma
John Warner ....................................................................................................................... 10
Prevention of Allergy and Asthma – Dream or Reality?
Ulrich Wahn ....................................................................................................................... 11
From Asthma Mechanisms to Therapy in Practice
Peter Barnes ....................................................................................................................... 12
Asthma and COPD - one or two diseases?
Ronald Dahl ....................................................................................................................... 12
The burden of allergy: The patients' Voice
Erkka Valovirta .................................................................................................................. 13
Asthma, COPD and rhinitis in primary care
David Price ......................................................................................................................... 14
Pediatric asthma: How significant it is for the whole life?
Petr Pohunek ...................................................................................................................... 15
The Role of Genetics in the Evaluation of Asthma and its Treatment
Stephen T Holgate ............................................................................................................. 16
Allergy and asthma in future
Tari Haahtela ..................................................................................................................... 17
Message of nose to bronchi
Ester Seberová ................................................................................................................... 18
„Fighting for Breath" European patients' perspective on living
with severe asthma symptoms
Donna Covey ..................................................................................................................... 18
Refractory bronchial asthma – approach to our patients.
Vladimír Koblížek, Vratislav Sedlák, Zdeòka Paráková,
Bohuslav Král, František Salajka ..................................................................................... 19
Burden of chronic obstructive pulmonary disease (COPD) in Czech Republic
Jaromír Musil ..................................................................................................................... 19
European Pollen Information Service – benefit for patients
Siegfried Jaeger .................................................................................................................. 20
Smoking - cause or trigger
Viktor Kašák ...................................................................................................................... 21
Intervention in the indoor environment
Ariana Lajčíková ................................................................................................................ 21
We and Europe against food allergies
Simona Bìlohlávková ........................................................................................................ 22
CZECH INITIATIVE FOR ASTHMA ........................................................................... 23
ALLERGY AND ASTHMA IN THE CZECH REPUBLIC
Lékař a pacient. Partner a partner.
Physician and patient. Partner&Partner.
Viliam Meissner ................................................................................................................ 25
Kvalita života nemocných s tìžkým astmatem
Quality of life in patients with severe asthma
František Salajka .............................................................................................................. 29
Průduškové astma – od dětství do dospělosti
Bronchial asthma – From Childhood to Adulthood
Petr Pohunek ...................................................................................................................... 32
Poselství nosu průduškám
Message of nose to bronchi
Ester Seberová .................................................................................................................. 35
Pětileté sledování gravidních astmatiček
Asthma in Pregnancy- 5 years follow-up
Bronislava Novotná, Tomáš Pavlík ................................................................................. 39
Obtížně léčitelné astma (OLA) – pøístup k pacientovi s těžkým astmatem
Refractory bronchial asthma – approach to our patients
Vladimír Koblížek, Vratislav Sedlák, Zdeòka Paráková,
Bohuslav Král, František Salajka ................................................................................... 46
Aspirinem zlepšené astma (AZA) – vzácný fenotyp astmatu?
Aspirin-ameliorated asthma - a rare phenotype of asthma?
Krčmová Irena, Král Bohuslav, Paráková Zdena, Sedlák Vratislav,
Novotná Bronislava, Kašák Viktor, Halíková Jana, Chmelařová Soňa ........................ 49
Indukované sputum v èasné diagnostice astmatu
Induced sputum in early diagnostic of Asthma
Petr Panzner, Ivana Malkusová, Vladimír Hraško ......................................................... 52
Pohybová aktivita dìtských astmatikù
Physical activity in asthmatic children
Hana Janíčková, Zuzana Smrčková,
Jana Nosálová, Milena Dědičová .................................................................................... 55
Intervence ve vnitøním prostředí
Intervention in the Indoor Environment
Ariana Lajčíková ............................................................................................................... 59
Pylová informaèní služba
Pollen Information Service
Ondøej Rybníček ............................................................................................................... 63
Evropa a my proti potravinové alergii
We and Europe against Food Allergies
Simona Bělohlávková ....................................................................................................... 66
Farmakoekonomika astmatu v České republice
Pharmacoeconomics of asthma in Czech Republic
Viktor Kašák ..................................................................................................................... 67

 

EDITORIAL
Václav Špičák, Vít Petrů ..................................................................... 3

Století specifické alergenové imunoterapie
Sublinguální alergenová imunoterapie
Václav Špičák ................................................................................... 4

Úvod ................................................................................................. 5

Kukátko do historie ............................................................................ 6

Alergeny ........................................................................................... 6

Specifická alergenová imunoterapie – od empirie k důkazům ................. 9

Sublinguální alergenová imunoterapie ................................................. 10

Od „Pollatinu" k ORALAIRU .............................................................. 12

ORALAIR v „medicíně založené na důkazech" .................................... 14

ORALAIR v klinické praxi .................................................................. 20

Budoucnost alergenové imunoterapie .................................................. 23

 

 

 

EDITORIAL
Václav Špičák, Vít Petrů .................................................................... 3

Century of the specific allergen immunotherapy
Sub-lingual allergen immunotherapy
Václav Špičák ................................................................................... 4

Introduction ....................................................................................... 5

Historical view ................................................................................... 6

Allergens .......................................................................................... 6

Specific allergen immunotherapy – from empiricism to evidence ............ 9

Sub-lingual allergen immunotherapy .................................................. 10

From „Pollatin" to ORALAIR ............................................................. 12

ORALAIR in „Evidence based medicine" ............................................ 14

ORALAIR in clinical practice ............................................................. 20

Future of allergen immunotherapy ...................................................... 23